Adaptimmune ^Companies

Adaptimmune is a clinical-stage biopharmaceutical company based in Abingdon, United Kingdom. They specialize in developing T cell therapies to treat cancer, human immunodeficiency virus (HIV), and infectious diseases. Their approach involves using affinity T cell receptor proteins to strengthen patient T cell responses and target and destroy cancerous or infected cells. Adaptimmune was incorporated in 2007 and is dedicated to treating challenging solid tumors using their proprietary cell therapy platform. They are on the verge of a new era in cancer immunotherapy and are committed to engineering a person's own cells to fight cancer.